The Baker-Polito Administration today announced the deployment of three state supported mobile units for monoclonal antibody treatment for high-risk individuals who have been exposed to or have COVID-19. These new clinics have the capacity to treat a combined 500 patients per week with therapies that have shown to be effective in reducing severity of disease and keeping COVID-19-positive individuals from being hospitalized. 

Referral from a health care provider is required for treatment at any of the three new mobile clinics.  Treatment is provided at no cost to the patient and offered regardless of immigration status or health insurance. Patients should discuss with their health care providers whether monoclonal antibody treatment is right for them.

Two of the new mobile units, currently in Fall River and Holyoke, began administering monoclonal antibody treatment (mAb) to patients on November 22nd, and a third unit will be deployed to Everett on December 3rd.  These mobile clinics will increase access to monoclonal antibody treatment in Massachusetts for high-risk individuals who have tested positive for COVID-19 or who have been exposed to someone with COVID-19. The mobile clinic sites can be relocated easily based on demand.